Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.
Publication
, Journal Article
Luo, N; Xu, H; Jneid, H; Fonarow, GC; Lopes, RD; Piccini, JP; Curtis, AB; Russo, AM; Lewis, WR; Matsouaka, RA; Granger, CB; Mentz, RJ; Al-Khatib, SM
Published in: Circ Heart Fail
October 2018
BACKGROUND: Stroke prophylaxis in patients with atrial fibrillation (AF) and heart failure (HF) in the era of direct oral anticoagulants is not well characterized. Using data from American Heart Association Get With The Guidelines-AFIB, we sought to evaluate oral anticoagulation (OAC) use at discharge among AF patients with concomitant HF. METHODS AND RESULTS: AF patients with a diagnosis of HF hospitalized from January 2013 to March 2017 were included. We compared patient characteristics and use of OAC at discharge among patients with reduced (redundant ejection fraction [EF], EF≤40%), borderline (40%
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circ Heart Fail
DOI
EISSN
1941-3297
Publication Date
October 2018
Volume
11
Issue
10
Start / End Page
e005356
Location
United States
Related Subject Headings
- Warfarin
- Risk Factors
- Practice Patterns, Physicians'
- Patient Discharge
- Humans
- Heart Failure
- Female
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Luo, N., Xu, H., Jneid, H., Fonarow, G. C., Lopes, R. D., Piccini, J. P., … Al-Khatib, S. M. (2018). Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail, 11(10), e005356. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005356
Luo, Nancy, Haolin Xu, Hani Jneid, Gregg C. Fonarow, Renato D. Lopes, Jonathan P. Piccini, Anne B. Curtis, et al. “Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.” Circ Heart Fail 11, no. 10 (October 2018): e005356. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005356.
Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, et al. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail. 2018 Oct;11(10):e005356.
Luo, Nancy, et al. “Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.” Circ Heart Fail, vol. 11, no. 10, Oct. 2018, p. e005356. Pubmed, doi:10.1161/CIRCHEARTFAILURE.118.005356.
Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, Curtis AB, Russo AM, Lewis WR, Matsouaka RA, Granger CB, Mentz RJ, Al-Khatib SM. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail. 2018 Oct;11(10):e005356.
Published In
Circ Heart Fail
DOI
EISSN
1941-3297
Publication Date
October 2018
Volume
11
Issue
10
Start / End Page
e005356
Location
United States
Related Subject Headings
- Warfarin
- Risk Factors
- Practice Patterns, Physicians'
- Patient Discharge
- Humans
- Heart Failure
- Female
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants